How a Republican president could affect Medicare drug negotiations

Posted on AllSides September 1st, 2023
From The Left
Healthcare, Prescription Drugs, Costs, Republican Party, 2024 Presidential Election
Illustration: Natalie Peeples/Axios

A future Republican president who opposes Medicare drug price negotiations likely couldn't dismantle or ignore the process but could have some regulatory discretion to seek lower price cuts, experts told Axios.

Why it matters: Giving Medicare the ability to negotiate drug prices was a signature achievement for President Biden. Republicans, meanwhile, have long opposed Medicare negotiations, regarding them as price controls that could hurt new drug development.

Driving the news: Biden this week announced the first 10 drugs that will be subject to negotiations — a process made possible through the Inflation Reduction Act....

Read full story

AllSides Picks

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right